Amphetamine and negative symptoms of schizophrenia

Psychopharmacology

Volumn 123, Issue 2, 1996, Pages 211-214

  Sanfilipo, Michael ^a   Wolkin, Adam ^a,b   Angrist, Burt ^a,b   Van Kammen, Daniel P ^a,c   Duncan, Erica ^a,b   Wieland, Susan ^a   Cooper, Thomas B ^d   Peselow, Eric D ^a,b   Rotrosen, John ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Amphetamine; Negative symptoms; Schizophrenia

Indexed keywords

DEXAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; MALE; NEGATIVE SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; AMPHETAMINE; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0030042663     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246180     Document Type: Article

References (18)

1. Abrams R, Taylor MA (1978) A rating scale for emotional blunting. Am J Psychiatry 135:226-229
2. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. DC:APA, Washington
3. Andreasen, NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784-788
4. Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 72:17-19
5. Angrist B, Pesclow E, Rubinstein M, Corwin J, Rotrosen J (1982) Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacology 78:128-130
6. Cesarec Z, Nyman AK. (1985) Differential response to amphetamine in schizophrenia. Acta Psychiatr Scand 71:523-538
7. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486
8. Goldberg TE, Bigelow LB, Weinberger DR, Daniel DG, Kleinman JE (1991) Cognitive and behavioral effects of coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 148:78-84
9. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsitivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24
10. Guy W (1976) ECDEU assessment manual for Psychopharmacology. US Department of Health, Education, and Welfare, Washington, DC, Publication No. (ADM), pp 534-535
11. Mathew RJ, Wilson WH (1989) Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients. Neuropsychobiology 21:117-123
12. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
13. Van Kammen DP, Boronow JJ (1988) Dextro-amphetamine diminishes negative symptoms in schizophrenia. Int Clin Psychopharmacol 3:111-121
14. Van Kammen DP, Bunney WE Jr, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982) d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991-997
15. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
16. Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J, Cancro R, Rotrosen J (1987) Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology 92:241-246
17. Wolkin A, Sanlilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992) Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49:959-965
18. Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP (1994) Acute d-amphetamine challenge in schizophrenia: effects on cerebal glucose utilization and clinical symptomatology. Biological Psychiatry 36:31-325